Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
101624,GNRL,"Pfizer Inc.",NY,100000000286,900.00,09/18/2014,GNRL,207304036
101624,GNRL,"Pfizer Inc.",NY,100000000286,94.00,09/09/2014,GNRL,206550136
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,75.70,01/16/2015,GNRL,260111354
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,74.99,09/09/2014,GNRL,156106338
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,74.99,09/05/2014,GNRL,168745364
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,69.00,11/26/2013,GNRL,31950485
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,69.00,02/07/2014,GNRL,216298712
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,65.03,04/14/2015,GNRL,332297001
101624,GNRL,"Pfizer Inc.",NY,100000000286,63.28,09/07/2013,GNRL,205179784
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,60.91,01/28/2014,GNRL,148876794
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,28.27,06/19/2014,GNRL,187931746
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,25.74,04/11/2014,GNRL,187850370
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,25.00,12/09/2015,GNRL,318838638
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,24.89,04/02/2014,GNRL,168657738
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,24.05,12/04/2014,GNRL,188173600
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.45,01/24/2014,GNRL,187742396
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.39,10/24/2013,GNRL,13997010
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,23.02,06/16/2015,GNRL,290589652
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,22.94,10/02/2013,GNRL,111802358
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.47,11/20/2014,GNRL,196485360
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.15,06/25/2014,GNRL,148844536
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.86,02/18/2015,GNRL,290589658
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,20.67,10/27/2014,GNRL,156106326
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.67,06/09/2015,GNRL,269765138
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,20.10,11/02/2015,GNRL,332489502
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,19.93,09/30/2014,GNRL,168761338
101624,GNRL,"Pfizer Inc.",NY,100000000286,19.92,04/01/2014,GNRL,206900892
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.80,11/20/2013,GNRL,101155356
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.76,05/28/2015,GNRL,331663345
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.68,10/19/2015,GNRL,290589796
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.47,07/27/2015,GNRL,331796829
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.27,09/18/2015,GNRL,331956159
101624,GNRL,"Pfizer Inc.",NY,100000000286,19.26,03/07/2014,GNRL,206335868
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.20,04/29/2015,GNRL,290589656
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,19.16,05/07/2014,GNRL,198194230
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.14,11/07/2013,GNRL,13989578
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,19.12,11/12/2013,GNRL,111805194
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.07,01/08/2015,GNRL,260088780
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.93,03/16/2015,GNRL,260104572
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,18.92,03/19/2015,GNRL,331569325
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.85,06/18/2014,GNRL,196485374
101624,GNRL,"LILLY USA, LLC",IN,100000000066,18.67,12/09/2013,GNRL,4739786
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,18.42,09/03/2014,GNRL,188050838
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.40,09/23/2013,GNRL,104437526
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.35,08/16/2013,GNRL,215695902
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.21,09/22/2014,GNRL,196485368
101624,GNRL,"Pfizer Inc.",NY,100000000286,18.11,11/26/2014,GNRL,205671732
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.71,12/12/2014,GNRL,188182434
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.68,12/21/2015,GNRL,290589790
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.62,03/01/2015,GNRL,269606570
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.53,02/03/2014,GNRL,196485388
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.49,10/12/2015,GNRL,332049709
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.46,09/06/2013,GNRL,104431992
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.33,10/06/2014,GNRL,198194207
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.30,01/13/2015,GNRL,269590492
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.20,04/28/2015,GNRL,339623722
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.17,03/17/2014,GNRL,198194234
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.02,10/15/2015,GNRL,260107550
101624,GNRL,"AbbVie, Inc.",IL,100000000204,16.94,09/06/2013,GNRL,104616068
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.94,12/03/2014,GNRL,188171138
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.94,11/06/2015,GNRL,339613572
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.90,01/09/2015,GNRL,331487795
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.88,02/21/2014,GNRL,196485384
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.70,12/03/2015,GNRL,275099110
101624,GNRL,"AbbVie, Inc.",IL,100000000204,16.67,03/05/2014,GNRL,189198316
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.48,11/16/2014,GNRL,162229922
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.48,05/11/2015,GNRL,294746222
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.44,10/28/2014,GNRL,188125440
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.39,07/30/2014,GNRL,161752570
101624,GNRL,"Lilly USA, LLC",IN,100000000066,16.32,05/29/2015,GNRL,267804590
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.28,10/14/2015,GNRL,275099090
101624,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.26,09/24/2013,GNRL,100859948
101624,GNRL,"Lilly USA, LLC",IN,100000000066,16.20,06/10/2015,GNRL,267804578
101624,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.14,06/27/2014,GNRL,199573952
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,16.02,07/08/2015,GNRL,318838617
101624,GNRL,"AbbVie, Inc.",IL,100000000204,16.01,11/14/2014,GNRL,189601970
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.93,01/20/2015,GNRL,336833322
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.91,10/28/2013,GNRL,31950483
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.90,04/01/2015,GNRL,260126610
101624,GNRL,"Lilly USA, LLC",IN,100000000066,15.89,11/17/2015,GNRL,267804594
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.88,06/26/2014,GNRL,161530146
101624,GNRL,"Pfizer Inc.",NY,100000000286,15.78,10/31/2014,GNRL,206775176
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.75,12/16/2013,GNRL,32316743
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.62,09/15/2015,GNRL,290589798
101624,GNRL,"LILLY USA, LLC",IN,100000000066,15.60,12/20/2013,GNRL,4738096
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.58,11/25/2015,GNRL,270246710
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.56,10/11/2013,GNRL,31950481
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,15.50,08/14/2015,GNRL,294954528
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,15.47,01/27/2015,GNRL,295117620
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.34,05/19/2014,GNRL,161370282
101624,GNRL,"Pfizer Inc.",NY,100000000286,15.30,11/17/2015,GNRL,323413924
101624,GNRL,"AbbVie, Inc.",IL,100000000204,15.30,03/12/2015,GNRL,309145808
101624,GNRL,"AbbVie, Inc.",IL,100000000204,15.28,09/17/2014,GNRL,189504460
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.20,08/21/2014,GNRL,198194220
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.19,07/09/2014,GNRL,156106350
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.03,05/20/2015,GNRL,318838588
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.94,12/11/2015,GNRL,339491220
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.92,12/17/2015,GNRL,260122562
101624,GNRL,"Lilly USA, LLC",IN,100000000066,14.84,07/10/2015,GNRL,267804588
101624,GNRL,"AbbVie, Inc.",IL,100000000204,14.84,09/16/2015,GNRL,317134476
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.81,02/17/2015,GNRL,318792704
101624,GNRL,"Pfizer Inc.",NY,100000000286,14.78,12/23/2013,GNRL,205922292
101624,GNRL,"Pfizer Inc.",NY,100000000286,14.75,06/24/2014,GNRL,206160040
101624,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,14.73,07/16/2015,GNRL,283340292
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.68,05/18/2015,GNRL,339479540
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,14.57,02/20/2014,GNRL,216298714
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.51,10/20/2014,GNRL,148870992
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.46,11/07/2014,GNRL,196485362
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.36,12/12/2014,GNRL,150951534
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.36,01/29/2015,GNRL,319010470
101624,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.33,10/08/2013,GNRL,100859950
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.26,04/14/2015,GNRL,275099112
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.22,01/19/2015,GNRL,275099084
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.18,03/04/2015,GNRL,275099086
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.17,03/28/2014,GNRL,156106320
101624,GNRL,"Pfizer Inc.",NY,100000000286,14.08,10/20/2015,GNRL,323554922
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.97,10/29/2014,GNRL,198194199
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.94,11/06/2013,GNRL,100932074
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.94,02/04/2014,GNRL,198194240
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.87,08/06/2015,GNRL,319444858
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.82,09/12/2014,GNRL,168387113
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.77,02/12/2014,GNRL,160690240
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.60,04/09/2015,GNRL,333469914
101624,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.54,06/17/2014,GNRL,199573948
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.54,01/16/2015,GNRL,260099728
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.53,03/20/2014,GNRL,148643216
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.49,12/12/2013,GNRL,23817917
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.41,07/06/2015,GNRL,290589650
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.40,04/15/2014,GNRL,156106328
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.27,10/26/2015,GNRL,290589794
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.25,11/14/2014,GNRL,156106346
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.23,05/07/2014,GNRL,196485378
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.20,12/15/2014,GNRL,216298718
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.19,09/02/2015,GNRL,260111426
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.18,09/27/2013,GNRL,23817913
101624,GNRL,"Pfizer Inc.",NY,100000000286,13.16,09/16/2014,GNRL,205951586
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.13,08/26/2013,GNRL,100895096
101624,GNRL,"Pfizer Inc.",NY,100000000286,13.12,04/01/2015,GNRL,322829140
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.10,09/04/2013,GNRL,101150200
101624,GNRL,"Purdue Pharma L.P.",CT,100000005432,13.07,09/25/2015,GNRL,251122920
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.01,08/27/2013,GNRL,101039072
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.84,08/03/2015,GNRL,260107402
101624,GNRL,"Pfizer Inc.",NY,100000000286,12.83,08/21/2015,GNRL,323438478
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.81,01/30/2015,GNRL,332345819
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.76,11/10/2015,GNRL,318615390
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.60,01/28/2015,GNRL,318838572
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.56,12/01/2014,GNRL,168903964
101624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,12.49,08/07/2014,GNRL,163285850
101624,GNRL,"LILLY USA, LLC",IN,100000000066,12.47,10/10/2014,GNRL,137653388
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.47,08/18/2015,GNRL,339349356
101624,GNRL,"Amgen Inc.",CA,100000000203,12.46,09/22/2015,GNRL,297377534
101624,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,12.42,03/03/2014,GNRL,216298716
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.30,11/21/2013,GNRL,104361408
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.25,07/03/2014,GNRL,168905340
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.15,09/17/2015,GNRL,260068286
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.12,02/24/2014,GNRL,149784400
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.06,05/13/2014,GNRL,150833626
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.05,05/02/2014,GNRL,161220180
101624,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.05,10/20/2015,GNRL,326175794
101624,GNRL,"Shire North American Group Inc",MA,100000061292,12.02,10/30/2015,GNRL,301102016
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.97,12/09/2013,GNRL,13989581
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.95,10/28/2015,GNRL,270034842
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.90,08/27/2015,GNRL,269955568
101624,GNRL,"Pfizer Inc.",NY,100000000286,11.84,03/06/2015,GNRL,322991428
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.81,09/09/2013,GNRL,32316744
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.81,06/04/2015,GNRL,275099120
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.77,06/25/2015,GNRL,260045838
101624,GNRL,"Shire North American Group Inc",MA,100000061292,11.76,08/25/2015,GNRL,300690855
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.74,12/04/2014,GNRL,150183328
101624,GNRL,"Shire North American Group Inc",MA,100000061292,11.70,05/21/2015,GNRL,300316740
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.68,01/30/2015,GNRL,269647350
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.67,07/20/2015,GNRL,294903786
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.66,11/04/2013,GNRL,23817915
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.66,10/21/2014,GNRL,156106344
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.63,12/18/2014,GNRL,162347736
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.59,09/20/2013,GNRL,215695904
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.57,05/22/2015,GNRL,319026065
101624,GNRL,"Pfizer Inc.",NY,100000000286,11.56,10/29/2013,GNRL,205724435
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.47,09/23/2014,GNRL,198194213
101624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,11.46,11/17/2014,GNRL,163228636
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.44,11/24/2014,GNRL,198194188
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.37,08/23/2015,GNRL,275099104
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.34,07/09/2015,GNRL,260092892
101624,GNRL,"Amgen Inc.",CA,100000000203,11.33,10/12/2015,GNRL,297377532
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.31,10/25/2013,GNRL,13965548
101624,GNRL,"LILLY USA, LLC",IN,100000000066,11.24,05/16/2014,GNRL,137600410
101624,GNRL,"Purdue Pharma L.P.",CT,100000005432,11.21,08/29/2013,GNRL,24374824
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.17,11/13/2014,GNRL,148280144
101624,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.16,02/05/2014,GNRL,199573940
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.12,07/31/2014,GNRL,196485372
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.09,02/13/2014,GNRL,196485386
101624,GNRL,"Lilly USA, LLC",IN,100000000066,11.09,02/03/2015,GNRL,267804592
101624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,11.04,12/19/2013,GNRL,101237098
101624,GNRL,"Shire US Holdings",PA,100000000241,11.03,10/17/2013,GNRL,6373714
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.03,06/03/2014,GNRL,198194224
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.01,04/09/2015,GNRL,337073456
101624,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.98,10/13/2015,GNRL,295065156
101624,GNRL,"Amgen Inc.",CA,100000000203,10.85,07/16/2014,GNRL,138201532
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.83,09/11/2015,GNRL,290589800
101624,GNRL,"Lilly USA, LLC",IN,100000000066,10.78,01/12/2015,GNRL,267804576
101624,GNRL,"Pfizer Inc.",NY,100000000286,10.75,12/30/2014,GNRL,207346642
101624,GNRL,"Pfizer Inc.",NY,100000000286,10.73,10/04/2013,GNRL,205040016
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.70,02/04/2015,GNRL,260126840
101624,GNRL,"Lilly USA, LLC",IN,100000000066,10.65,05/04/2015,GNRL,267804580
101624,GNRL,"Pfizer Inc.",NY,100000000286,10.61,10/14/2014,GNRL,207079096
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.60,04/03/2014,GNRL,149969126
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.60,11/04/2014,GNRL,196485364
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.56,08/20/2015,GNRL,275099094
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.55,08/05/2013,GNRL,32316745
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.55,09/19/2013,GNRL,13997009
101624,GNRL,"Shionogi Inc",NJ,100000005589,10.52,01/10/2014,GNRL,217448992
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.52,01/23/2015,GNRL,290589660
101624,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,10.50,03/05/2015,GNRL,283340290
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.50,12/07/2015,GNRL,332218147
101624,GNRL,"Pfizer Inc.",NY,100000000286,10.49,02/14/2014,GNRL,206463654
101624,GNRL,"Amgen Inc.",CA,100000000203,10.42,03/02/2015,GNRL,297377530
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.41,11/20/2015,GNRL,332218111
101624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,10.39,03/27/2014,GNRL,163276722
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.28,12/08/2014,GNRL,196485524
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.28,10/22/2014,GNRL,196485366
101624,GNRL,"Pfizer Inc.",NY,100000000286,10.28,01/15/2015,GNRL,322927620
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.25,10/31/2013,GNRL,13997008
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.21,04/04/2014,GNRL,196485380
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.17,10/08/2015,GNRL,337372524
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.11,08/10/2015,GNRL,290589802
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.10,04/11/2014,GNRL,193925556
101624,GNRL,"Pfizer Inc.",NY,100000000286,10.01,06/05/2014,GNRL,206414258
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.00,09/30/2015,GNRL,275099098
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.00,05/05/2015,GNRL,275099114
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.96,11/09/2015,GNRL,290589792
101624,GNRL,"Pfizer Inc.",NY,100000000286,9.96,05/15/2015,GNRL,323846156
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.91,12/03/2013,GNRL,215695900
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.84,04/06/2015,GNRL,339138790
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,9.64,08/09/2013,GNRL,14029711
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.60,04/30/2015,GNRL,290589654
101624,GNRL,"Pfizer Inc.",NY,100000000286,9.59,08/13/2015,GNRL,323931210
101624,GNRL,"Pfizer Inc.",NY,100000000286,9.40,08/08/2014,GNRL,205746310
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.36,04/17/2015,GNRL,319096561
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.26,08/15/2014,GNRL,196485370
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.17,05/20/2014,GNRL,196485376
101624,GNRL,"Pfizer Inc.",NY,100000000286,9.16,04/07/2015,GNRL,322461438
101624,GNRL,"Pfizer Inc.",NY,100000000286,9.05,03/13/2014,GNRL,206921870
101624,GNRL,"Pfizer Inc.",NY,100000000286,9.04,05/07/2015,GNRL,322446135
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.96,06/02/2014,GNRL,156106334
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.95,12/18/2015,GNRL,323712440
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.82,10/09/2013,GNRL,205516390
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.76,07/22/2015,GNRL,339098484
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.75,06/06/2014,GNRL,161474486
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.75,03/06/2014,GNRL,206866666
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.67,04/02/2015,GNRL,319646915
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.66,03/25/2015,GNRL,323299794
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.66,01/05/2015,GNRL,339095734
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.61,11/05/2013,GNRL,205715634
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.56,12/14/2015,GNRL,270248598
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.56,02/05/2015,GNRL,323946202
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.53,06/12/2015,GNRL,319780714
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.48,07/28/2014,GNRL,156106340
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.38,08/06/2015,GNRL,323471038
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.34,02/13/2015,GNRL,323090636
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.32,01/29/2014,GNRL,160922660
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.28,10/27/2015,GNRL,319606952
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.23,10/03/2014,GNRL,162176834
101624,GNRL,"Pfizer Inc.",NY,100000000286,8.23,01/03/2014,GNRL,206595642
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.17,09/14/2015,GNRL,270012718
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.06,10/09/2015,GNRL,339078932
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.02,04/07/2014,GNRL,156106330
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.00,05/29/2014,GNRL,156106324
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.95,02/26/2014,GNRL,196485382
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.91,11/05/2015,GNRL,270099814
101624,GNRL,"Pfizer Inc.",NY,100000000286,7.85,11/13/2013,GNRL,205882556
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,7.84,10/16/2013,GNRL,13997007
101624,GNRL,"Pfizer Inc.",NY,100000000286,7.82,09/03/2015,GNRL,322984760
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.74,04/08/2014,GNRL,161133508
101624,GNRL,"LILLY USA, LLC",IN,100000000066,7.58,12/13/2013,GNRL,4730071
101624,GNRL,"Pfizer Inc.",NY,100000000286,7.58,07/29/2015,GNRL,323928414
101624,GNRL,"Pfizer Inc.",NY,100000000286,7.48,12/20/2013,GNRL,205642034
101624,GNRL,"Pfizer Inc.",NY,100000000286,7.42,09/19/2014,GNRL,205664142
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.34,02/02/2015,GNRL,336874034
101624,GNRL,"Pfizer Inc.",NY,100000000286,7.13,05/08/2014,GNRL,206832564
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.06,03/23/2015,GNRL,339053804
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.98,02/25/2015,GNRL,318514540
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.91,11/23/2015,GNRL,323895226
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.89,09/11/2014,GNRL,206753558
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.74,08/12/2013,GNRL,205864469
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.74,02/27/2014,GNRL,206448960
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.73,03/13/2015,GNRL,319573129
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.61,09/12/2014,GNRL,206368050
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.59,04/24/2014,GNRL,205593613
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.57,02/17/2015,GNRL,339040342
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.47,09/01/2015,GNRL,318910408
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.47,06/30/2015,GNRL,318835952
101624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.25,07/21/2015,GNRL,318546574
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.17,11/17/2015,GNRL,275099106
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.15,05/22/2014,GNRL,207361472
101624,GNRL,"Pfizer Inc.",NY,100000000286,6.13,10/21/2015,GNRL,323882710
101624,GNRL,"Pfizer Inc.",NY,100000000286,5.87,08/14/2013,GNRL,205419714
101624,GNRL,"Pfizer Inc.",NY,100000000286,5.86,11/26/2014,GNRL,205699058
101624,GNRL,"Pfizer Inc.",NY,100000000286,5.86,11/18/2015,GNRL,322683490
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.81,10/20/2015,GNRL,339022118
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.73,07/14/2015,GNRL,269860348
101624,GNRL,"Pfizer Inc.",NY,100000000286,5.68,02/10/2015,GNRL,323983620
101624,GNRL,"Pfizer Inc.",NY,100000000286,5.62,01/15/2014,GNRL,206793354
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,5.59,01/30/2014,GNRL,196485390
101624,GNRL,"Pfizer Inc.",NY,100000000286,5.02,10/18/2013,GNRL,205221008
101624,GNRL,"Lilly USA, LLC",IN,100000000066,4.73,08/10/2015,GNRL,267804598
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.06,06/15/2015,GNRL,338977888
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.00,05/13/2014,GNRL,161242872
101624,GNRL,"Pfizer Inc.",NY,100000000286,3.99,08/24/2015,GNRL,323313060
101624,GNRL,"Pfizer Inc.",NY,100000000286,3.90,03/31/2015,GNRL,323311372
101624,GNRL,"Pfizer Inc.",NY,100000000286,3.82,04/23/2015,GNRL,323918620
101624,GNRL,"Pfizer Inc.",NY,100000000286,3.25,05/18/2015,GNRL,322814766
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3.20,10/21/2013,GNRL,13965549
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.07,12/04/2014,GNRL,162397274
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.95,07/28/2014,GNRL,156106352
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.59,09/15/2015,GNRL,323814280
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.53,08/17/2015,GNRL,322792132
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.46,06/20/2014,GNRL,206606378
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.40,01/30/2015,GNRL,269570350
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.27,12/31/2015,GNRL,323913470
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.14,10/12/2015,GNRL,323574528
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.14,05/12/2015,GNRL,323409282
101624,GNRL,"Pfizer Inc.",NY,100000000286,2.13,09/25/2015,GNRL,323020702
101624,GNRL,"Lilly USA, LLC",IN,100000000066,2.06,12/18/2015,GNRL,267804582
101624,GNRL,"Lilly USA, LLC",IN,100000000066,2.04,12/18/2015,GNRL,267804584
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.95,11/07/2013,GNRL,13989580
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.89,08/05/2014,GNRL,161901158
101624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,1.86,12/19/2013,GNRL,101237100
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.85,11/06/2015,GNRL,338891492
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.83,07/14/2015,GNRL,269867570
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.66,09/16/2014,GNRL,156106342
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.64,10/21/2015,GNRL,323992666
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.61,07/31/2014,GNRL,205961824
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.61,11/05/2015,GNRL,270100251
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.55,02/13/2014,GNRL,206613370
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.53,10/25/2013,GNRL,13965547
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.51,12/05/2013,GNRL,205172914
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.50,12/09/2015,GNRL,323401576
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.48,01/15/2014,GNRL,206499700
101624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,12/21/2015,GNRL,290140476
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.47,02/13/2015,GNRL,323828488
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.46,10/29/2013,GNRL,206008230
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.46,12/04/2015,GNRL,322917960
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.42,10/01/2015,GNRL,275099100
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.40,08/08/2014,GNRL,161866734
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.39,05/02/2014,GNRL,161220158
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.36,12/03/2015,GNRL,275099108
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.34,04/23/2014,GNRL,205563222
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.29,07/28/2014,GNRL,161660554
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.28,11/26/2014,GNRL,206809232
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.21,03/24/2015,GNRL,323915190
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.18,10/09/2013,GNRL,205059706
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.18,01/28/2014,GNRL,206520050
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.17,08/14/2013,GNRL,205033122
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.17,03/02/2015,GNRL,323639922
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.13,04/07/2015,GNRL,323753872
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.09,01/28/2014,GNRL,207199852
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.08,10/09/2014,GNRL,206647070
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.08,09/12/2014,GNRL,206905780
101624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1.07,06/25/2014,GNRL,148530306
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.06,12/20/2013,GNRL,206083350
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.06,04/08/2014,GNRL,161133518
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.04,03/04/2015,GNRL,275099088
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.03,12/14/2015,GNRL,270126890
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.03,08/17/2015,GNRL,323550609
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.00,10/06/2015,GNRL,322851270
101624,GNRL,"Pfizer Inc.",NY,100000000286,1.00,10/29/2015,GNRL,322853336
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.95,06/09/2015,GNRL,322896554
101624,GNRL,"Lilly USA, LLC",IN,100000000066,0.94,12/18/2015,GNRL,267804586
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.93,03/13/2014,GNRL,207181736
101624,GNRL,"Lilly USA, LLC",IN,100000000066,0.93,08/10/2015,GNRL,267804596
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.93,09/14/2015,GNRL,270012700
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.92,01/29/2014,GNRL,160927282
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.90,11/20/2013,GNRL,205351098
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.90,10/14/2014,GNRL,206880794
101624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.89,04/10/2014,GNRL,193925552
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.89,05/08/2015,GNRL,323517618
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.88,08/07/2015,GNRL,322707854
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.87,11/23/2015,GNRL,323845808
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.86,08/20/2015,GNRL,275099096
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.85,04/13/2015,GNRL,275099092
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.82,12/18/2015,GNRL,323948684
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.79,12/09/2013,GNRL,13989579
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.78,05/22/2014,GNRL,206380932
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.77,11/23/2015,GNRL,322908936
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.76,05/02/2014,GNRL,161220146
101624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.75,08/09/2013,GNRL,14029712
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.74,09/24/2014,GNRL,206285814
101624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,0.73,08/07/2014,GNRL,163267114
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.71,05/19/2014,GNRL,161371246
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.71,09/24/2014,GNRL,206199162
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.70,06/06/2014,GNRL,161474505
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.68,02/27/2014,GNRL,206973047
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.67,03/31/2015,GNRL,323875380
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.60,11/05/2013,GNRL,206090680
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.60,02/10/2015,GNRL,322749286
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.58,08/23/2015,GNRL,275099102
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.57,11/20/2013,GNRL,205905826
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.56,06/05/2014,GNRL,207172314
101624,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.54,01/30/2015,GNRL,269570248
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.53,07/09/2014,GNRL,156106348
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.53,12/30/2014,GNRL,206476384
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.52,10/06/2014,GNRL,198194204
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.49,12/23/2013,GNRL,205242974
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.49,08/12/2013,GNRL,205305165
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.49,03/28/2014,GNRL,156106332
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.49,01/03/2014,GNRL,207198138
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.48,11/06/2015,GNRL,338861378
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.47,06/04/2015,GNRL,275099118
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.47,08/17/2015,GNRL,323857246
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.46,05/29/2014,GNRL,156106322
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.46,05/05/2015,GNRL,275099116
101624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.45,06/02/2014,GNRL,156106336
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.45,06/24/2014,GNRL,206831128
101624,GNRL,"LILLY USA, LLC",IN,100000000066,0.44,12/13/2013,GNRL,4738762
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.42,01/13/2015,GNRL,323360590
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.41,10/04/2013,GNRL,205695440
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.35,08/17/2015,GNRL,323295763
101624,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.35,06/15/2015,GNRL,338857912
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.32,02/10/2015,GNRL,323189276
101624,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.27,05/06/2014,GNRL,198194226
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.27,07/29/2015,GNRL,322703560
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.20,10/18/2013,GNRL,205724270
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.18,08/08/2014,GNRL,206832498
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.18,10/21/2015,GNRL,323502729
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.15,10/29/2013,GNRL,205566708
101624,GNRL,"Pfizer Inc.",NY,100000000286,0.10,12/15/2015,GNRL,322962892
